Immunotherapy. 2013;5(9):923-925. Rather than focusing on the blockade of IL-17A or IL-17F alone, Wedebye Schmidt et al. examined the effects of blockade of both IL-17A and IL-17F. They report that ...
A new study examines the association between IL-17F and treatment response to interferon beta-1b among patients with relapsing-remitting multiple sclerosis. A study by Hans-Peter Hartung, M.D., of ...
Please provide your email address to receive an email when new articles are posted on . The use of bimekizumab to inhibit IL-17A and IL-17F was well-tolerated and impactful in improving axial SpA ...
KAWASAKI, Japan, December 17, 2025--(BUSINESS WIRE)--PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter "PeptiDream")(Tokyo: 4587) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results